Respironics to Webcast Fiscal 2008 First Quarter Conference Call
17 Octubre 2007 - 8:00AM
PR Newswire (US)
MURRYSVILLE, Penn., Oct. 17 /PRNewswire-FirstCall/ -- Respironics,
Inc. (NASDAQ:RESP), a recognized resource in the medical device
market, announced today that it intends to release its first
quarter results for the period ending September 30, 2007 on
Thursday October 25, 2007. In conjunction with this release and to
review the Company's results and business outlook, Respironics will
host a conference call that will be broadcast simultaneously live
over the Internet. Individuals wishing to participate on the
Webcast, to be held at 8:30 a.m. EST on Thursday October 25, 2007,
can access the event at the Company's web site at
http://www.respironics.com/. Please allow extra time prior to the
call to visit the site and download the streaming media software
required to listen to the Internet broadcast. The online archive of
the broadcast will be available within 2 hours of the live call and
will be available for 30 days. Respironics is a leading developer,
manufacturer and distributor of innovative products and programs
that serve the global sleep and respiratory markets. Focusing on
emerging market needs, the Company is committed to providing valued
solutions to help improve outcomes for patients, clinicians and
healthcare providers. Respironics markets its products in 141
countries and employs over 5,100 associates worldwide. Further
information can be found on the Company's Web site:
http://www.respironics.com/. FORWARD-LOOKING STATEMENT This
document contains forward-looking statements, including statements
relating to, among other things, developments in the healthcare
industry; the success of the Company's marketing, sales, and
promotion programs; future sales, acceptance, and quality of the
Company's products and programs; the results of clinical trials;
the timing and success of new product introductions; new product
development; anticipated cost savings; FDA and other regulatory
requirements, enforcement actions, product recalls or related field
actions; future results from acquisitions and strategic
investments; growth rates in foreign markets; regulations and other
factors affecting operations and sales outside the United States;
foreign currency fluctuations; the effects of a major natural
disaster, cyber-attack or other catastrophic event that results in
the destruction or disruption of any critical business or
information technology systems; customer consolidation and
concentration; increasing price competition and other competitive
factors in the manufacture, distribution, and sale of products;
interest rate fluctuations; expiration of intellectual property
rights; intellectual property and related litigation; other
litigation; future levels of earnings and revenues; the number of
equity awards granted to employees and changes in the Company's
stock price; and third party reimbursement; all of which are
subject to change. Actual results may differ materially from those
described in any forward-looking statements. Additional information
on potential factors that could affect the Company's financial
results are included in the reports filed with the SEC, including
the reports on Form 10-K, 10-Q and 8-K. (C) 2007 Respironics, Inc.
and its affiliates. All rights reserved. DATASOURCE: Respironics,
Inc. CONTACT: Dan Bevevino, Vice President & CFO of Financial
Relations Board, +1-724-387-5235 Web site:
http://www.respironics.com/
Copyright
Respironics (NASDAQ:RESP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Respironics (NASDAQ:RESP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Respironics (MM) (NASDAQ): 0 recent articles
Más de Respironics (MM) Artículos de Noticias